Prometheus Biosciences, Inc. Profile Avatar - Palmy Investing

Prometheus Biosciences, Inc.

Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product incl…

Biotechnology
US, San Diego [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Prometheus Biosciences, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Prometheus Biosciences, Inc. can't present revenue by segment

End of RXDX's Analysis
CIK: 1718852 CUSIP: 74349U108 ISIN: US74349U1088 LEI: - UEI: -
Secondary Listings
RXDX has no secondary listings inside our databases.